Market Overview:
The global melanoma therapeutics market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of melanoma, rising awareness about melanoma and its treatment options, and technological advancements in the field of melanoma therapeutics. The global melanoma therapeutics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into chemotherapy, immunotherapy, targeted therapy radiation therapy,, and others. Immunotherapy dominates this market owing to its high efficacy in treating advanced-stage tumors as well as its ability to prevent tumor recurrence. By application,, hospitals account for a majority share in this market followed by clinics,. Geographically,, North America dominates this market followed by Europe,. However,. Asia Pacific is expected to witness highest growth during the forecast period due.
Product Definition:
Melanoma therapeutics are drugs used to treat melanoma, a type of skin cancer. Melanoma is the most dangerous form of skin cancer, and can be fatal if not treated. There are a number of different therapies available for melanoma, including chemotherapy, radiation therapy, and surgery. The importance of melanoma therapeutics is that they can save lives by treating this deadly form of cancer.
Chemotherapy:
Chemotherapy is a medical treatment used to treat cancer. Chemotherapies are drugs and/or radiation therapy used to control or stop the growth of cancer. The major goal of chemotherapy is to reduce the size or halt the progression of tumors by either decreasing their ability to grow or by killing off existing cells that carry the genetic mutation that causes tumor growth.
Immunotherapy:
Immunotherapy is a treatment wherein the body's immune system is stimulated and encouraged to fight cancerous cells. There are various types of immunotherapies, including checkpoint inhibitors, cytokine therapies, tumor vaccines, and monoclonal antibodies. The most common type of melanoma that spreads to other parts of the body is known as cutaneous melanoma; it accounts for 90% of all skin cancers.
Application Insights:
The others segment held the largest share of 66.7% in 2017. This is due to the increasing prevalence of skin cancer and growing interest among patients for non-invasive treatment options. Increasing awareness about skin cancer and its symptoms, coupled with rising availability of advanced therapies, is anticipated to boost market growth over the forecast period.
The clinics application segment is expected to witness lucrative growth during the forecast period owing to an increase in demand for minimally invasive treatments that offer faster results with fewer side effects as compared to conventional surgeries or procedures.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased adoption of novel therapies, and high incidence rate of melanoma. In addition, increasing number of research collaborations between universities and hospitals and pharmaceutical companies is expected to further boost growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising prevalence of skin cancer coupled with growing healthcare expenditure in emerging countries such as China & India. Moreover, availability & accessibility drugs at a cheaper price will also help this region gain significant share over the next eight years time frame.
Growth Factors:
- Increasing incidence of melanoma
- Growing awareness about melanoma and its symptoms
- Rising demand for better and more effective treatment options for melanoma patients
- Technological advancements in the field of melanoma therapeutics 5. Growing investments in research and development of new therapies for treating melanoma
Scope Of The Report
Report Attributes
Report Details
Report Title
Melanoma Therapeutics Market Research Report
By Type
Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Others
By Application
Hospitals, Clinics, Others
By Companies
AstraZeneca, Amgen, Inc., Roche., Bristol-Myers Squibb Company, Novartis AG, Merck & Co., Inc., Daiichi Sankyo Company, Limited, AB Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Melanoma Therapeutics Market Report Segments:
The global Melanoma Therapeutics market is segmented on the basis of:
Types
Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Amgen, Inc.
- Roche.
- Bristol-Myers Squibb Company
- Novartis AG
- Merck & Co., Inc.
- Daiichi Sankyo Company, Limited
- AB Sciences
Highlights of The Melanoma Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Radiation Therapy
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Melanoma Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Melanoma Therapeutics is a biotechnology company focused on the development of novel therapies for melanoma. The company's lead product candidate, MT-101, is an investigational therapy that targets the BRAF V600E mutation in advanced melanoma.
Some of the major players in the melanoma therapeutics market are AstraZeneca, Amgen, Inc., Roche., Bristol-Myers Squibb Company, Novartis AG, Merck & Co., Inc., Daiichi Sankyo Company, Limited, AB Sciences.
The melanoma therapeutics market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Melanoma Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Melanoma Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Melanoma Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Melanoma Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Melanoma Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Melanoma Therapeutics Market Size and Y-o-Y Growth
4.5.2 Melanoma Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Melanoma Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Melanoma Therapeutics Market Size Forecast by Type
5.2.1 Chemotherapy
5.2.2 Immunotherapy
5.2.3 Targeted Therapy
5.2.4 Radiation Therapy
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Melanoma Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Melanoma Therapeutics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Melanoma Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Melanoma Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Melanoma Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Melanoma Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Melanoma Therapeutics Market Size Forecast by Type
9.6.1 Chemotherapy
9.6.2 Immunotherapy
9.6.3 Targeted Therapy
9.6.4 Radiation Therapy
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Melanoma Therapeutics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Melanoma Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Melanoma Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Melanoma Therapeutics Market Size Forecast by Type
10.6.1 Chemotherapy
10.6.2 Immunotherapy
10.6.3 Targeted Therapy
10.6.4 Radiation Therapy
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Melanoma Therapeutics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Melanoma Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Melanoma Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Melanoma Therapeutics Market Size Forecast by Type
11.6.1 Chemotherapy
11.6.2 Immunotherapy
11.6.3 Targeted Therapy
11.6.4 Radiation Therapy
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Melanoma Therapeutics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Melanoma Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Melanoma Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Melanoma Therapeutics Market Size Forecast by Type
12.6.1 Chemotherapy
12.6.2 Immunotherapy
12.6.3 Targeted Therapy
12.6.4 Radiation Therapy
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Melanoma Therapeutics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Melanoma Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Melanoma Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Melanoma Therapeutics Market Size Forecast by Type
13.6.1 Chemotherapy
13.6.2 Immunotherapy
13.6.3 Targeted Therapy
13.6.4 Radiation Therapy
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Melanoma Therapeutics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Melanoma Therapeutics Market: Competitive Dashboard
14.2 Global Melanoma Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca
14.3.2 Amgen, Inc.
14.3.3 Roche.
14.3.4 Bristol-Myers Squibb Company
14.3.5 Novartis AG
14.3.6 Merck & Co., Inc.
14.3.7 Daiichi Sankyo Company, Limited
14.3.8 AB Sciences
